Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 187.60
-7.39 (-3.79%)
Oct 23, 2026, 12:30 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 249.37 billion as of October 22, 2026. It is the 5,417th most valuable company in the world and the 311th biggest in India. Its market cap has decreased by 4.81% in one year.
Market Cap
249.37B
Enterprise Value
292.94B
Revenue
92.05B
Global Rank
Country Rank
#311 India
PE Ratio
n/a
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 249.37B, an increase of 9.99%. That is a compound annual growth rate of 2.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 249.37B | 9.05% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 486.83B |
| Gland Pharma | 484.18B |
| Ajanta Pharma | 407.32B |
| Emcure Pharmaceuticals | 332.91B |
| Wockhardt | 305.03B |
| Cohance Lifesciences | 176.68B |
| Eris Lifesciences | 157.65B |
| Alembic Pharmaceuticals | 154.88B |